Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn’s and Colitis Organisation (ECCO)
February 18, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
ADP Research: Only 24% of Global Workers Are Confident They Have Skills for Career Advancement
Study examines the untapped potential of workers in the first of a…
Kosmos Energy to Host Fourth Quarter 2024 Results and Webcast on February 24, 2025
DALLAS--(BUSINESS WIRE)--Kosmos Energy (NYSE/LSE: KOS) announced today the following schedule for its…
Canoo Inc. Announces 1-for-20 Reverse Stock Split Effective December 24, 2024
December 20, 2024 06:00 ET | Source: Canoo, Inc. JUSTIN, Texas, Dec.…
Zenflow Announces $24 Million Financing Round to Fund FDA Filing & Commercial Preparation
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Zenflow, Inc.,…